A top pick in smallcap health. They made PPP during Covid then bought two companies in home healthcare. Sales rose 24% in 2023, though PPP declined. They just projected EPS growing 20% annually.
Your Watchlist
Add stocks to watchlist to monitor them daily and get important alerts.